Shawn Cross insider trades

Open-market stock purchases and sales by Shawn Cross, Chief Financial Officer at Pacira BioSciences, Inc, from SEC Form 4 filings since Mar 1, 2021.

Recent trades

DateStockTradeValue
Apr 23, 2026PCRX Pacira BioSciences, IncSold$326K
Apr 23, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Apr 22, 2026PCRX Pacira BioSciences, IncSold$37.5K
Apr 22, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Apr 21, 2026PCRX Pacira BioSciences, IncSold$71.2K
Apr 21, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Apr 20, 2026PCRX Pacira BioSciences, IncSold$194K
Apr 20, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Feb 11, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Dec 10, 2025PCRX Pacira BioSciences, IncSold$229K
Dec 10, 2025PCRX Pacira BioSciences, IncBought (not open market)—
Dec 9, 2025PCRX Pacira BioSciences, IncSold$398K
Dec 9, 2025PCRX Pacira BioSciences, IncBought (not open market)—
Nov 10, 2025PCRX Pacira BioSciences, IncSold$266K
Oct 31, 2025PCRX Pacira BioSciences, IncSold (not open market)$143K

Companies traded

  • PCRX Pacira BioSciences, Inc: 7 sales, last Apr 23, 2026
  • CYTH Cyclo Therapeutics, Inc: other filings, last Feb 27, 2025
  • AMTI Applied Molecular Transport Inc: 15 sales, last Dec 27, 2023

Get free alerts when Shawn Cross files a new trade →